Like the talons of its namesake, Eagle Pharmaceuticals specializes in sharps. The firm develops and commercializes injectable treatments, primarily to address unmet needs in oncology and critical care. The company has five FDA-approved products -- blood thinner Argatroban, malignant hyperthermia treatment Ryanodex, anti-inflammatory drug diclofenac-misoprostol, cancer drug Non-Alcohol Docetaxel Injection, and leukemia and non-Hodgkin lymphoma treatment Bendeka. Eagle Pharmaceuticals also has a handful of candidates under development. Commercial and development partners include Cephalon, Albany Molecular Research, Sandoz, and The Medicines Company.